Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value—A Multicenter Study From South India
Publication date: May 2020Source: Clinical Lymphoma Myeloma and Leukemia, Volume 20, Issue 5Author(s): Shashidhar V. Karpurmath, Arun Seshachalam, Kalaiselvi Selvaraj, Priyadarshini Rajamani, Satish kumar, Neelesh Reddy, Baswant Malipatil, Roopa Sirigeri, Krishna Prasad, Krishna Reddy, Madhav Danthala, Karthik S. Udupa, Manjunath Nandennavar, Janarthinakani Murugesan, C.N. Patil, Parameswaran Anoop, Roshan Koshy Jacob, Mallikarjun Kalashetty, Krishnakumar Rathnam, Ramanan Ganapathy
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | India Health | Leukemia | Lymphoma | Myeloma | Study